Literature DB >> 34959022

Analysis of clinical characteristics of Kounis syndrome induced by contrast media.

Chunjiang Wang1, Zhenzhen Deng1, Liying Song1, Wei Sun1, Weijin Fang1, Zuojun Li2.   

Abstract

BACKGROUND: Understanding the relationship between contrast agents and Kounis syndrome (KS) is mainly based on case reports. The purpose of this research is to explore the clinical characteristics of contrast media induced KS.
METHODS: We searched for contrast-induced KS case reports through Chinese and English databases from 1991 to October 31, 2021.
RESULTS: A total of 26 patients (19 men and 7 women,) were included, with a median age of 60 years (range 30-83). The contrast agents that cause KS mainly included gadolinium-based contrast agent (7 cases), iodine-containing contrast media (12 cases). KS mainly occurred within 30 min after administration and mainly manifests as chest pain and allergic reactions. Electrocardiogram (ECG) mainly showed ST elevation. Echocardiography mainly revealed normal. Coronary angiography showed normal, coronary vasospasm, stent thrombosis, occlusion and stenosis. After treatment with steroids, antihistamines and anti-ischemic therapy, 24 patients recovered completely and 2 patients died.
CONCLUSIONS: KS is a rare adverse reaction of contrast media. Radiologists should recognize this rare but serious disease to ensure rapid diagnosis and proper management.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Contrast media; Coronary vasospasm; Iodine contrast media; Kounis syndrome

Mesh:

Substances:

Year:  2021        PMID: 34959022     DOI: 10.1016/j.ajem.2021.12.036

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  1 in total

1.  Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.

Authors:  Alberto Navarro-Navajas; Ingrid Casallas; Daniel Isaza; Paola Ortiz; Daniela Baracaldo-Santamaría; Carlos-Alberto Calderon-Ospina
Journal:  Medicina (Kaunas)       Date:  2022-06-26       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.